Feb 24, 2026Chronic Allergic Inflammation in Aging: Mechanisms and Evidence-Based ManagementAllergic inflammation can worsen with immune senescence, contributing to systemic inflammatory load. This article covers the evidence for dietary and supplement interventions that modulate allergic response without the side effects of antihistamines.
Feb 24, 2026Inflammaging: Chronic Low-Grade Inflammation in Aging, Causes, and Intervention EvidenceInflammaging — the chronic low-grade inflammatory state that accumulates with age — is now recognized as a driver of virtually every major age-related disease. Senescent cells, gut dysbiosis, and visceral fat are the primary sources. Targeted interventions address the root causes, not just the biomarkers.
Feb 24, 2026Joint Health and Cartilage Support: What the Evidence ShowsCartilage has limited self-repair capacity, but several interventions modestly slow degradation and reduce symptoms. Here is what the clinical evidence supports for joint health in aging.
Feb 23, 2026Periodontal Disease and Aging: The Overlooked Systemic RiskPeriodontal disease is a chronic inflammatory condition linked to cardiovascular disease, diabetes, and cognitive decline. Here is what the evidence shows about management beyond brushing.
Feb 20, 2026Gout and Uric Acid: Evidence-Based Management Beyond MedicationGout is driven by uric acid crystal deposition, but diet, supplements, and lifestyle all modulate uric acid levels. Here is what the evidence shows.
Jan 26, 2026Managing Chronic Inflammation: Multi-Modal Protocol with Supplements, Diet, Sleep, and ExerciseChronic low-grade inflammation drives aging-related disease across multiple organ systems. An evidence-based protocol combines dietary modification, omega-3 supplementation, sleep optimization, exercise, and targeted anti-inflammatory compounds.
Jan 20, 2026Astaxanthin: Marine Carotenoid, Oxidative Stress, and Exercise Recovery EvidenceAstaxanthin is a potent marine carotenoid with evidence for reducing exercise-induced oxidative stress and muscle damage markers. Its lipophilic structure and singlet oxygen quenching capacity make it notably effective compared to other antioxidants.
Jan 5, 2026Curcumin and Chronic Inflammation: Evidence, Dosing, and BioavailabilityCurcumin reduces inflammatory markers in multiple RCTs, but poor oral bioavailability limits standard formulations. Piperine co-dosing and liposomal forms substantially improve absorption.